Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia

JAMA

Volumn 303, Issue 18, 2010, Pages 1823-1831

  Vichinsky, Elliott P ^a   Neumayr, Lynne D ^a   Gold, Jeffrey I ^b,c   Weiner, Michael W ^d   Rule, Randall R ^d   Truran, Diana ^d   Kasten, Jeffrey ^d   Eggleston, Barry ^e   Kesler, Karen ^e   McMahon, Lillian ^f   Orringer, Eugene P ^g   Harrington, Thomas ^h   Kalinyak, Karen ⁱ   De Castro, Laura M ^j   Kutlar, Abdullah ^k   Rutherford, Cynthia J ^a,l   Johnson, Cage ^b   Bessman, Joel David ^m   Jordan, Lanetta B ⁿ   Armstrong, F Daniel ^h  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e RHO INC   (United States)

^f BOSTON MEDICAL CENTER   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

ⁱ CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^j DUKE UNIVERSITY MEDICAL CENTER   (United States)

^k MEDICAL COLLEGE OF GEORGIA   (United States)

^l UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^m UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

ⁿ Memorial Cancer Institute   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN A;

ADULT; ANEMIA; ARTICLE; ATTENTION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GRAY MATTER; HEMOGLOBIN BLOOD LEVEL; HIPPOCAMPUS; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TASK PERFORMANCE; WECHSLER INTELLIGENCE SCALE; WHITE MATTER; WORKING MEMORY; AGE; BRAIN; BRAIN HYPOXIA; CASE CONTROL STUDY; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; INTELLIGENCE TEST; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; AGE FACTORS; ANEMIA; ANEMIA, SICKLE CELL; BRAIN; CASE-CONTROL STUDIES; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPOXIA, BRAIN; INTELLIGENCE TESTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 77952297450     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.562     Document Type: Article

References (37)

1. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639-1644. (Pubitemid 124005049)
2. Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore). 2005;84(6):363-376. (Pubitemid 41668935)
3. McClish DK, Penberthy LT, Bovbjerg VE, et al. Health related quality of life in sickle cell patients: the PiSCES project. Health Qual Life Outcomes. 2005; 3:50.
4. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288-294. (Pubitemid 28018756)
5. Manfrè L, Giarratano E, Maggio A, Banco A, Vaccaro G, Lagalla R. MR imaging of the brain: findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease. AJR Am J Roentgenol. 1999;173(6):1477-1480.
6. Pegelow CH, Macklin EA, Moser FG, et al. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood. 2002; 99(8):3014-3018.
7. Marouf R, Gupta R, Haider MZ, Adekile AD. Silent brain infarcts in adult Kuwaiti sickle cell disease patients. Am J Hematol. 2003;73(4):240-243. (Pubitemid 36898880)
8. Silva GS, Vicari P, Figueiredo MS, Carrete H Jr, Idagawa MH, Massaro AR. Brain magnetic resonance imaging abnormalities in adult patients with sickle cell disease: correlation with transcranial Doppler findings. Stroke. 2009;40(7):2408-2412.
9. Armstrong FD, Thompson RJ Jr, Wang W, et al; Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Pediatrics. 1996;97(6, pt 1): 864-870.
10. Adams RJ. Big strokes in small persons. Arch Neurol. 2007;64(11):1567- 1574.
11. Steen RG, Miles MA, Helton KJ, et al. Cognitive impairment in children with hemoglobin SS sickle cell disease: relationship to MR imaging findings and hematocrit. AJNR Am J Neuroradiol. 2003;24(3): 382-389.
12. Steen RG, Fineberg-Buchner C, Hankins G, Weiss L, Prifitera A, Mulhern RK. Cognitive deficits in children with sickle cell disease. J Child Neurol. 2005; 20(2):102-107. (Pubitemid 40484847)
13. Hogan AM, Pit-ten Cate IM, Vargha-Khadem F, Prengler M, Kirkham FJ. Physiological correlates of intellectual function in children with sickle cell disease: hypoxaemia, hyperaemia and brain infarction. Dev Sci. 2006;9(4):379-387. (Pubitemid 43855817)
14. Bernaudin F, Verlhac S, Freard F, et al. Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. J Child Neurol. 2000;15(5):333-343. (Pubitemid 30341365)
15. Kral MC, Brown RT, Connelly M, et al. Radiographic predictors of neurocognitive functioning in pediatric sickle cell disease. J Child Neurol. 2006; 21(1):37-44. (Pubitemid 43778763)
16. Schatz J, White DA, Moinuddin A, Armstrong M, DeBaun MR. Lesion burden and cognitive morbidity in children with sickle cell disease. J Child Neurol. 2002; 17(12):891-895. (Pubitemid 36231052)
17. Nahavandi M, Tavakkoli F, Hasan SP, Wyche MQ, Castro O. Cerebral oximetry in patients with sickle cell disease. Eur J Clin Invest. 2004;34(2):143-148. (Pubitemid 38253615)
18. Folstein MF, Folstein SE, McHugh PH. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
19. McNair DM, Lorr M, Droppleman L. Manual for the Profile of Mood States. San Diego, CA: EDITS; 1992.
20. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice. http://www.ich.org/LOB/media/ MEDIA482.pdf. 1996. Accessed April 6, 2010.
21. Christensen GE, Joshi SC, Miller MI. Volumetric transformation of brain anatomy. IEEE Trans Med Imaging. 1997;16(6):864-877.
22. Van Leemput K, Maes F, Vandermeulen D, Suetens P. A unifying framework for partial volume segmentation of brain MR images. IEEE Trans Med Imaging. 2003;22(1):105-119.
23. Dawant BM, Hartmann SL, Thirion JP, Maes F, Vandermeulen D, Demaerel P. Automatic 3-D segmentation of internal structures of the head in MR images using a combination of similarity and free-form transformations: I, methodology and validation on normal subjects. IEEE Trans Med Imaging. 1999;18 (10):909-916. (Pubitemid 32211106)
24. Studholme C, Cardenas V, Maudsley A, Weiner M. An intensity consistent filtering approach to the analysis of deformation tensor derived maps of brain shape. Neuroimage. 2003;19(4):1638-1649. (Pubitemid 37025860)
25. Karavanen J. The statistical basis of laboratory data normalization. Drug Inf J. 2003;37:101-107.
26. Wechsler D. Wechsler Memory Scale (WMSIII): Administration and Scoring Manual. 3rd ed. San Antonio, TX: Psychological Corp; 1997.
27. Ehlhardt LA, Sohlberg MM, Kennedy M, et al. Evidence-based practice guidelines for instructing individuals with neurogenic memory impairments: what have we learned in the past 20 years? Neuropsychol Rehabil. 2008;18(3):300-342. (Pubitemid 351874172)
28. Schatz J, McClellan CB. Sickle cell disease as a neurodevelopmental disorder. Ment Retard Dev Disabil Res Rev. 2006;12(3):200-207. (Pubitemid 44646329)
29. Pegelow CH, Colangelo L, Steinberg M, et al. Natural history of blood pressure in sickle cell disease: risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med. 1997; 102(2):171-177. (Pubitemid 27122999)
30. Mercuri E, Faundez JC, Roberts I, et al. Neurological "soft" signs may identify children with sickle cell disease who are at risk for stroke. Eur J Pediatr. 1995;154(2):150-156.
31. Quinn CT, Variste J, Dowling MM. Haemoglobin oxygen saturation is a determinant of cerebral artery blood flow velocity in children with sickle cell anaemia. Br J Haematol. 2009;145(4):500-505.
32. Puffer E, Schatz J, Roberts CW. The association of oral hydroxyurea therapy with improved cognitive functioning in sickle cell disease. Child Neuropsychol. 2007;13(2):142-154. (Pubitemid 46393106)
33. Weiskopf RB, Kramer JH, Viele M, et al. Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology. 2000;92(6): 1646-1652. (Pubitemid 30412484)
34. Pickett JL, Theberge DC, Brown WS, Schweitzer SU, Nissenson AR. Normalizing hematocrit in dialysis patients improves brain function. Am J Kidney Dis. 1999;33(6):1122-1130.
35. Helton KJ, Paydar A, Glass J, et al. Arterial spin-labeled perfusion combined with segmentation techniques to evaluate cerebral blood flow in white and gray matter of children with sickle cell anemia. Pediatr Blood Cancer. 2009;52(1):85-91.
36. Steen RG, Xiong X, Mulhern RK, Langston JW, Wang WC. Subtle brain abnormalities in children with sickle cell disease: relationship to blood hematocrit. Ann Neurol. 1999;45(3):279-286. (Pubitemid 29120031)
37. Grueneich R, Ris MD, Ball W, et al. Relationship of structural magnetic resonance imaging, magnetic resonance perfusion, and other disease factors to neuropsychological outcome in sickle cell disease. J Pediatr Psychol. 2004;29(2):83-92. (Pubitemid 38608033)